Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil®AerolizerTM) with salbutamol (VentodiskTM) von BENHAMOU, D., CUVELIER, A., MUIR, J.F., LECLERC, V., LE GROS, V., KOTTAKIS, J., BOURDEIX, I.

Volltext

Comparison of the Efficacy, Tolerability, and Safety of Formoterol Dry Powder and Oral, Slow-Release Theophylline in the Treatment of COPD von Rossi, Andrea, Kristufek, Peter, Levine, Bernard E., Thomson, Moira H., Till, Denise, Kottakis, John, Della Cioppa, Giovanni

Volltext

Formoterol (Foradil® Aerolizer®) protects against exercise-induced bronchoconstriction von Yegen, U., Till, D., Ziehmer, B., Kottakis, J.

Volltext

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma von Bouros, D, Bachlitzanakis, N, Kottakis, J, Pfister, P, Polychronopoulos, V, Papadakis, E, Constantopoulos, S, Froudarakis, M, Sichletidis, L, Siafakas, N

Volltext

Formoterol (Foradil ®) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma von Mitchell, C., Jenkins, C., Scicchitano, R., Rubinfeld, A., Kottakis, J.

Volltext

Comparable Efficacy and Tolerability of Formoterol (Foradil®) Administered via a Novel Multi-Dose Dry Powder Inhaler (Certihaler™) or the Aerolizer® Dry Powder Inhaler in Patients... von Dahl, R., Creemers, J.P., van Noord, J., Sips, A., Della Cioppa, G., Thomson, M., Andriano, K., Kottakis, J., Fashola, T.

Volltext

BRONCHODILATORY RESPONSES TO FORMOTEROL, IPRATROPIUM, AND THEIR COMBINATION IN PATIENTS WITH STABLE COPD von Sichletidis, L, Kottakis, J, Marcou, S, Constantinidis, TC, Antoniades, A

Volltext

FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer® in chronic obstructive pulmonary disease von Muir, J-F., Benhamou, D., Cuvelier, A., Le Gros, V., Overend, T., Till, D., Cioppa, G. Della, Kottakis, J.

Volltext

CLINICAL EFFICACY WITH FORMOTEROL IN THE ABSENCE OF A RESPONSE TO SALMETEROL: A REVIEW von Kottakis, J, Wood, R, Gros, V Le, Cioppa, G Bella

Volltext

SIMILAR EFFICACY FOLLOWING FOUR WEEKS TREATMENT OF ASTHMATICS WITH FORMOTEROL 12 μG B.D. DELIVERED BY TWO DIFFERENT DRY POWDER INHALERS: DIFFERENCES IN INHALER HANDLING von Eliraz, A, Ramirez‐Rivera, A, Ferranti, P, Holzer, R, Garcí, JM Ignacio, Turcotte, C, Rapatz, G, Pfister, P, Overend, T, Kottakis, J

Volltext

In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium A 3-week, randomized, double-bl... von D'URZO, Anthony D, DE SALVO, Maria Cristina, RAMIREZ-RIVERA, Alicia, ALMEIDA, Joao, SICHLETIDIS, Lazaros, RAPATZ, Guenter, KOTTAKIS, John

Volltext

Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler von Lötvall, J, Mellén, A, Arvidsson, P, Palmqvist, M, Radielovic, P, Kottakis, J, Pfister, P

Volltext

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV1 reversibility von Bouros, Demosthenes, Kottakis, John, Gros, Vincent Le, Overend, Tim, Cioppa, Giovanni Della, Siafakas, Nikolaos

Volltext

Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults von Bronsky, Edwin A., Grossman, Jay, Henis, Marc J., Gallo, Paul P., Yegen, Ümit, Cioppa, Giovanni Della, Kottakis, John, Mehra, Sunil

Volltext

Formoterol Therapy for Chronic Obstructive Pulmonary Disease: A Review of the Literature von Friedman, Mitchell, Cioppa, Giovanni Della, Kottakis, John

Volltext

A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol von Shapiro, Gail S., Yegen, Ümit, Xiang, Jim, Kottakis, John, Cioppa, Giovanni Della

Volltext

Formoterol Delivered via a Dry Powder Inhaler (Aerolizer): Results from Long-term Clinical Trials in Children von Pearlman, David S., Kottakis, John, Till, Denise, Cioppa, Giovanni Della

Volltext

FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer® in chronic obstructive pulmonary disease: Prediction of Formoterol Effect by Fev1 Reversibility von Muir, J-F., Benhamou, D., Cuvelier, A., Le Gros, V., Overend, T., Till, D., Cioppa, G. Della, Kottakis, J.

Volltext

Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling von Eliraz, A, Ramirez-Rivera, A, Ferranti, P, Holzer, R, García, J M, Turcotte, C, Rapatz, G, Pfister, P, Overend, T, Kottakis, J

Volltext

Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persi... von Chuchalin, Alexander G, Manjra, Ahmed I, Rozinova, Nadezhda N, Skopková, Olga, Cioppa, Giovanni Della, Till, Denise, Kaiser, Guenther, Fashola, Taiwo, Kottakis, John

Volltext